Updates In Lupus

Updates In Lupus is organized by University of Michigan (U-M) Department of Internal Medicine.

Description:
This course will discuss the basics of lupus management and then broaden to discuss the management of lupus nephritis, including a discussion of new FDA-approved medications. It will also cover efforts to address disparities in lupus care and outcomes and the latest research ongoing to improve our treatment of lupus patients.

Learning Objectives:
At the end of this activity, participants should be able to:
• identify the role of hydroxychloroquine in the standard of care lupus management.
• describe the role of immunosuppressants and which ones to choose in SLE.
• list the barriers to proper care in lupus patients.
• differentiate the patients that may benefit from voclosporin and belimumab for lupus nephritis.
• research new therapies in the pipeline and how they may benefit patients with SLE.

Additional details will be posted as soon as information is available.